Patients that were not treated with nebulized colistin had a tendency to develop more frequent septic shock, though results failed to reach statistical significance (66.7% in Group A vs. 86.8% in Group B patients, p = 0.065).
← all excerpts
Co-Administration of High-Dose Nebulized Colistin for <i>Acinetobacter baumannii</i> Bacteremic Ventilator-Associated Pneumonia: Impact on Outcomes.
1
0.0650
0.0650